Assignee
IVACHTCHENKO ALEXANDRE VASILIEVICH
US·10 granted patents·16 pending applications·13 citations·filing 2011–2023
Top patents by PatentIndex Score
26 records- 0180US9428491B2Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2011·Granted Aug 30, 2016·3 cites·3 claims
- 0279US10266558B2Macroheterocyclic nucleoside derivatives and their analogues, production and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2016·Granted Apr 23, 2019·2 cites·4 claims
- 0375US10683315B2Prodrug of an HCV NS5B polymerase inhibitor and method of production and application thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2017·Granted Jun 16, 2020·1 cites·6 claims
- 0475US9073874B2Cyclic N,N′-diarylthioureas and N,N′-diarylureas-androgen receptor antagonists, anticancer agent, method for preparation and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2011·Granted Jul 7, 2015·3 cites·5 claims
- 0572US9085539B2Cyclic N,N′-diarylthiourea—androgen receptor antagonist, anti breast cancer composition and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2013·Granted Jul 21, 2015·1 cites·5 claims
- 0669US2023346899A1PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + NIRMATRELVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDING COVID-19IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2023·Application pending·0 cites
- 0768US9790207B2Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methodsIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2015·Granted Oct 17, 2017·1 cites·10 claims
- 0868US8829002B2Substituted methyl amines, serotonin 5-HT6 receptor antagonists, methods for production and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2011·Granted Sep 9, 2014·2 cites·15 claims
- 0962US2025032598A1Compounds, Pharmaceuticals, Formulations, and Methods for Treating and Preventing RNA Virus Infections and Associated DiseasesIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2023·Application pending·0 cites
- 1057US2023310480A1PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + MOLNUPIRAVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2022·Application pending·0 cites
- 1157US2023310544A1ANTI-RNA VIRAL PHARMACEUTICAL COMBINATION THERAPY WITH APROTININ + anti-RNA DRUGIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2022·Application pending·0 cites
- 1257US2023310467A1PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2022·Application pending·0 cites
- 1351US9655886B2Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2015·Granted May 23, 2017·0 cites·8 claims
- 1451US2023372458A1Antiviral agent for combined therapy of covid-19 (sars-cov-2)IVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2020·Application pending·0 cites
- 1548US9381201B2Pharmaceutical composition and kit for treating bacterial infectionsIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2012·Granted Jul 5, 2016·0 cites·3 claims
- 1648US2022096421A1Active Ingredient, Pharmaceutical Composition, and Medicinal Product for HIV and AIDS TherapyIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2020·Application pending·0 cites
- 1747US2023181704A1Anti-sars-cov-2 virus agent antiprovirIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2020·Application pending·0 cites
- 1844US2019054109A1An antiviral composition and a method for application thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2017·Application pending·0 cites
- 1944US2016031927A1Alkyl 2--propionates, nucleoside inhibitors of HCV RNA-polymerase NS5B, methods for preparation and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2014·Application pending·0 cites
- 2041US9370576B2Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using sameIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2013·Granted Jun 21, 2016·0 cites·15 claims
- 2139US2013196991A1Substituted indoles, antiviral active component, method for preparation and use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2011·Application pending·0 cites
- 2239US2020079814A1Nucleotides comprising an N-[(S)-1-cyclobutoxycarbonyl]phosphoramidate moiety and analogs and application thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2017·Application pending·0 cites
- 2338US2019374557A1Cyclobutyl (S)-2-[[[(R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-phenoxy-phosphoryl]amino]-propanoates, and production process and application thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2017·Application pending·0 cites
- 2438US2013267551A1Substituted hydrogenated thieno-pyrrolo[3,2-c]pyridine, ligands, a pharmaceutical composition and a method for using the aboveIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2011·Application pending·0 cites
- 2537US2019233409A1Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for use thereofIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2017·Application pending·0 cites
- 2635US2018030080A1Phosphoramidate nucleoside prodrug for treating viral diseases and cancer, processes for their preparation and their useIVACHTCHENKO ALEXANDRE VASILIEVICH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IVACHTCHENKO ALEXANDRE VASILIEVICH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →